These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 25409409

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Journal of Hypertension. Introduction.
    Chalmers J, Zanchetti A.
    J Hypertens Suppl; 2007 Jun; 25(1):S1-2. PubMed ID: 17579312
    [No Abstract] [Full Text] [Related]

  • 23. [Blood pressure before blood glucose treatment].
    Hubert M.
    MMW Fortschr Med; 2015 Jun 11; 157(11):72. PubMed ID: 26049364
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
    Jabbour SA.
    Postgrad Med; 2014 Jan 11; 126(1):111-7. PubMed ID: 24393758
    [Abstract] [Full Text] [Related]

  • 26. Accuracy of anthropometric indexes of obesity to predict diabetes mellitus type 2 among men and women with hypertension.
    Marcadenti A, Fuchs SC, Moreira LB, Wiehe M, Gus M, Fuchs FD.
    Am J Hypertens; 2011 Feb 11; 24(2):175-80. PubMed ID: 20885370
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM).
    Basile JN.
    J Diabetes Complications; 2013 Feb 11; 27(3):280-6. PubMed ID: 23375850
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Integrated drug therapy of the metabolic syndrome].
    Julius U, Hanefeld M.
    Internist (Berl); 1996 Jul 11; 37(7):722-30. PubMed ID: 8766266
    [No Abstract] [Full Text] [Related]

  • 32. Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
    Xie XX, Liu P, Wan FY, Lin SG, Zhong WL, Yuan ZK, Zou JJ, Liu LB.
    Int J Cardiol; 2016 Apr 01; 208():141-6. PubMed ID: 26855067
    [No Abstract] [Full Text] [Related]

  • 33. [Hypertension and diabetes - dangerous syntropy].
    Rett K.
    MMW Fortschr Med; 2017 Oct 01; 159(18):42-45. PubMed ID: 29071615
    [No Abstract] [Full Text] [Related]

  • 34. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
    van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GE.
    Pharmacoepidemiol Drug Saf; 2009 Nov 01; 18(11):983-91. PubMed ID: 19623570
    [Abstract] [Full Text] [Related]

  • 35. [Decreased blood pressure helps every diabetic patient long term].
    Zidek W.
    MMW Fortschr Med; 2015 Apr 02; 157(6):36. PubMed ID: 26015199
    [No Abstract] [Full Text] [Related]

  • 36. [Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].
    Jahn E, Sausele T.
    Med Monatsschr Pharm; 2009 Nov 02; 32(11):402-7. PubMed ID: 19947303
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Glucagon-like peptide-1 analogues for type 2 diabetes.
    Wilding JP, Hardy K.
    BMJ; 2011 Feb 16; 342():d410. PubMed ID: 21325387
    [No Abstract] [Full Text] [Related]

  • 39. Empagliflozin for the treatment of Type 2 diabetes.
    Gangadharan Komala M, Mather A.
    Expert Rev Clin Pharmacol; 2014 May 16; 7(3):271-9. PubMed ID: 24716752
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.